10.25384/SAGE.7441256.v2 G. Caleb Alexander G. Caleb Alexander Ken Ogasawara Ken Ogasawara Dana Wiegand Dana Wiegand Dora Lin Dora Lin Christopher D. Breder Christopher D. Breder Supplemental Material, 812058_web_appendix - Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016 SAGE Journals 2019 drug approval regulatory affairs expedited programs 2019-11-26 13:08:07 Journal contribution https://sage.figshare.com/articles/journal_contribution/Supplemental_Material_812058_web_appendix_-_Clinical_Development_of_Biologics_Approved_by_the_US_Food_and_Drug_Administration_2003-2016/7441256 <p>Supplemental Material, 812058_web_appendix for Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016 by G. Caleb Alexander, Ken Ogasawara, Dana Wiegand, Dora Lin, and Christopher D. Breder in Therapeutic Innovation & Regulatory Science</p>